Your session is about to expire
← Back to Search
Virtual Reality for Cervical Cancer Comfort During Brachytherapy
Study Summary
This trial is testing if VR can help people during cancer treatment by distracting them from the pain and making them more comfortable.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Sequence Group A
- Group 2: Sequence Group B
- Group 3: Sequence Group C
- Group 4: Sequence Group D
Frequently Asked Questions
Are researchers still accepting participants for this experiment?
"This medical experiment, which was first advertised on August 8th 2022, is currently recruiting patients. The record for the trial has been revised as recently as August 31st of this same year."
How many volunteers has this trial enrolled thus far?
"That is accurate. The clinicaltrials.gov page highlights that this medical trial was first announced on August 8th 2022 and has since been modified as recently as the 31st of the same month. 20 volunteers are needed from a single location for enrollment into the study."
What is the primary objective of this investigation?
"Over a 3-week period, the primary assessment of this trial will be tracking the number of participants who abandon or are removed from it. Secondary outcomes encompass benzodiazepine dose comparison between sessions with/without virtual reality (VR), evaluation of VR's ability to distract patients during brachytherapy treatment for cervical cancer and its effect on anxiety levels, as well as opioid dose comparisons."
Share this study with friends
Copy Link
Messenger